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Abstract: Empirical prediction models that weight food frequency questionnaire (FFQ) 
food items by their relation to nutrient biomarker concentrations may estimate nutrient 
exposure better than nutrient intakes derived from food composition databases. 
Carotenoids may especially benefit because contributing foods vary in bioavailability and 
assessment validity. Our objective was to develop empirical prediction models for the 
major plasma carotenoids and total carotenoids and evaluate their validity compared with 
dietary intakes calculated from standard food composition tables. 4180 nonsmoking 
women in the Nurses’ Health Study (NHS) blood subcohort with previously measured 
plasma carotenoids were randomly divided into training (n = 2787) and testing (n = 1393) 
subsets. Empirical prediction models were developed in the training subset by stepwise 
selection from foods contributing ≥0.5% to intake of the relevant carotenoid. Spearman 
correlations between predicted and measured plasma concentrations were compared to 
Spearman correlations between dietary intake and measured plasma concentrations for 
each carotenoid. Three to 12 foods were selected for the α-carotene, β-carotene,  
β-cryptoxanthin, lutein/zeaxanthin, lycopene, and total carotenoids prediction models. In 
the testing subset, Spearman correlations with measured plasma concentrations for the 
calculated dietary intakes and predicted plasma concentrations, respectively, were 0.31 and 
0.37 for α-carotene, 0.29 and 0.31 for β-carotene, 0.36 and 0.41 for β-cryptoxanthin, 0.28 
and 0.31 for lutein/zeaxanthin, 0.22 and 0.23 for lycopene, and 0.22 and 0.27 for total 
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carotenoids. Empirical prediction models may modestly improve assessment of some 
carotenoids, particularly α-carotene and β-cryptoxanthin. 
Keywords: carotenoids; vitamin A; α-carotene; β-carotene; β-cryptoxanthin; 
lutein/zeaxanthin; lycopene; food predictors; biomarkers 
 
1. Introduction 
Food frequency questionnaires (FFQ) are often used to assess usual dietary intake in epidemiologic 
studies. Responses are typically translated to nutrient intakes by multiplying reported consumption 
frequencies of commonly-used units or portion sizes of food items by the nutrient contents of the 
specified unit and summing over all foods. Nutrient contents are determined from several sources, 
including the USDA nutrient database [1], scientific journal articles, and manufacturer information. 
However, an individual’s nutrient intake determined this way may not adequately represent their 
internal dose, which is often more etiologically-relevant. This potential inadequacy may be due to 
factors such as responder interpretation of the FFQ; nutrient content data inaccuracy; individual 
differences in absorption, metabolism, or other physiologic or lifestyle factors; and nutrient 
bioavailability [2]. An alternative method is to utilize empirical prediction models that weight foods by 
their relation to biological nutrient (biomarker) levels, such as plasma concentrations [2]. This method 
reduces error from inaccurate food composition data, bioavailability differences among foods, and 
variation in the validity of questions on individual foods. Error may be introduced if the empirical 
weights are imprecise or not generalizable to the population of interest [2]. Whether error associated 
with empirical weight-based methods impacts validity more or less than error associated with nutrient 
composition-based methods is generally unknown. The impact may vary across studies because the 
precision of the empirical weights and thus degree of random error depends on sample size. 
Empirical prediction models may be particularly suited for nutrients obtained from foods with 
highly varying bioavailability and assessment validity. One such class of nutrients is carotenoids, 
acquired mainly from fruit and vegetable intake. Carotenoid bioavailability varies across different 
foods and different forms of the same food [3–6]. Based on the correlation corrected for within-person 
variation, assessment validity with respect to diet records is good for some carotenoid-containing foods 
(e.g., orange/grapefruit juice (r = 0.84), eggs (r = 0.77)), but lower for others (carrots (r = 0.40), yellow 
squash (r = 0.49)) [7]. Given observed inverse associations between dietary intake of certain carotenoids 
and estrogen receptor negative breast cancer [8] and late age-related macular degeneration [9], improved 
carotenoid assessment is of interest. We developed empirical prediction models for plasma 
concentrations of individual and total carotenoids and compared the correlations with measured plasma 
concentrations for the predicted plasma concentrations versus calculated dietary intakes. We thus 
extend a previous β-carotene analysis [10] to other carotenoids, a larger sample size, and updated 
nutrient composition data. 
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2. Subjects and Methods 
The Nurses’ Health Study (NHS) was established in 1976 when 121,700 female registered nurses in 
the United States aged 30–55 completed a mailed questionnaire regarding medical history and other 
health-related exposures. The women have been followed biennially by mailed self-administered 
questionnaires. In 1989–1990, 32,826 NHS participants provided blood samples. Details of the blood 
collection have been published previously [11]. In brief, women arranged to have their blood drawn 
and shipped, via overnight courier with an icepack, to our laboratory where samples were immediately 
centrifuged, aliquoted, and stored in liquid nitrogen freezers. Ninety-seven percent of samples were 
received within 26 h of collection. 
This study includes participants from nested case-control studies of breast cancer (n = 2313), 
cataract (n = 652), colorectal cancer (n = 361), colorectal adenoma (n = 589), and myocardial 
infarction (n = 265) for whom plasma carotenoid concentrations were assayed. To avoid subclinical 
breast or colon cancer impacting carotenoid intake or bioavailability, women diagnosed with either 
disease ≤2 years after blood collection were excluded (n = 168). 
Plasma carotenoid concentrations were assayed in batches by the Micronutrient Analysis 
Laboratory in the Department of Nutrition at the Harvard School of Public Health using reverse-phase 
HPLC by the methods described by El-Sohemy et al. [12]. Blinded quality control samples (10%) 
were randomly placed throughout batches and technicians were blinded to case-control status. 
Coefficients of variation (CV) were calculated within each laboratory batch. Across the 12 batches for 
each biomarker, CVs were generally <15% except for one batch for β-carotene (CV = 20.7%),  
two batches for β-cryptoxanthin (CVs = 19.4%, 20.6%), and one batch for lycopene (CV = 17.5%). 
Total carotenoids were summed from the five assayed carotenoids. One β-carotene, 4 β-cryptoxanthin, 
and thus 5 total carotenoids values were missing due to laboratory technical difficulties. 
Total plasma cholesterol was assayed in 15 batches using the enzymatic methods described by 
Allain et al. [13]. Coefficients of variation were 2.1%–15.6%. Plasma cholesterol data were not 
available for 426 women. 
All included participants completed FFQs in 1986 and 1990. FFQs were considered complete if a 
woman reported a plausible total energy intake (600–3500 kcal/day), left ≤70 food items blank, and 
did not skip the fruit or vegetable sections. Nutrient intakes were calculated by multiplying reported 
consumption frequencies of commonly-used units or portion sizes of food items by the nutrient 
contents of the specified unit and summing over all foods. Food nutrient values were derived primarily 
from USDA sources. Use of multivitamins and other supplements, as well as dose and duration of use, 
were incorporated into β-carotene intake. The FFQ reproducibility and validity has been reported 
previously [7,14,15]. The correlation between FFQ-estimated vitamin A intake from food and 
supplements versus 4, 1-week diet records was 0.49; validity for specific carotenoids was not 
calculated [15]. Carotenoid intakes were adjusted for total energy intake by the residual method [2]. As 
the association between dietary β-carotene intake and plasma β-carotene concentrations may be 
obscured by threshold effects among women with high supplemental β-carotene intake (e.g., dietary 
intake may impact plasma levels to a lesser extent much among women taking supplements),  
107 women who reported β-carotene supplement use and/or had a supplemental β-carotene intake 
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≥5054 μg/day (the amount in one medium carrot [1]) in 1990 were excluded from the β-carotene and 
total carotenoids analyses. 
To reduce within-person variation, nutrient and food intakes were averaged from the 1986 and 1990 
FFQs, except for six items on the 1986 but not 1990 FFQ. 
Non-dietary variables were obtained from biennial or blood collection questionnaires. Menopausal 
status and postmenopausal hormone use were determined from a questionnaire completed at the time 
of blood collection. Date of birth and height were determined from the baseline NHS questionnaire. 
Body mass index (BMI) was calculated using height reported in 1976 and weight reported on the blood 
collection questionnaire, or the 1990 (n = 104) or 1998 (n = 2) questionnaire if missing. The median 
BMI value for all women was used for women missing all weights or height (n = 5). Smoking status 
was determined from the 1990 NHS questionnaire; 659 women reporting current smoking were 
excluded. The final total sample included 4180 women, of whom 2241 were controls. The study 
protocol was approved by the Institutional Review Board of Brigham and Women’s Hospital. 
Statistical Analysis 
Plasma carotenoid values were natural log-transformed to improve normality. Outlying carotenoid 
concentrations were identified within batch by a generalized extreme Studentized deviate many-outlier 
detection method [16]; outlying plasma cholesterol concentrations were identified across all batches by 
the same method. Consequently, 3–21 values of individual carotenoids and 2 cholesterol values were set 
to missing. To account for laboratory variation that was evident across batches due to batches being 
assayed at different times, plasma carotenoid concentrations were standardized to an average batch with 
a method used previously to account for study effects among eleven blood pressure studies [17]. 
To remove variation in plasma carotenoid levels due to non-dietary factors, we obtained residuals 
from multivariate linear regression of each natural log-transformed plasma carotenoid on the following 
covariates: age (years), case-control status (indicators for breast cancer, colorectal cancer, colorectal 
adenoma, myocardial infarction, and cataract), BMI, plasma cholesterol (mg/dL), and menopausal 
status and hormone therapy (HT) use (premenopausal; postmenopausal, no HT; postmenopausal, HT; 
unknown). For interpretability, the mean natural log-transformed plasma concentration of the relevant 
carotenoid was added back to each residual. These adjusted values are hereafter referred to as plasma 
concentrations and used in all analyses. 
To select foods for the empirical prediction models and provide unbiased estimates of model 
performance after food selection, participants were randomly divided into two groups: a two-thirds 
training subset (n = 2787) and a one-third testing subset (n = 1393). Candidate food predictors were all 
foods contributing ≥0.5% to total intake of the relevant carotenoid in the full cohort (Table S1). 
Supplemental β-carotene (mg/day) in 1990 was also a candidate predictor for β-carotene and total 
carotenoids. Percent contribution of each food to total intake was determined by averaging the 
percentages across FFQs administered in 1986 and 1990. To determine each food’s average percent 
contribution to total carotenoids intake, each food’s average percent contribution to each carotenoid 
was weighted by each carotenoid’s percent contribution to total carotenoids intake in our sample (i.e., 
α-carotene = 5.4%, β-carotene = 28.8%, β-cryptoxanthin = 1.4%, lutein/zeaxanthin = 20.4%, and 
lycopene = 44.0%) and then summed across carotenoids for each food. In the training subset, foods 
Nutrients 2013, 5 4055 
 
were chosen by stepwise selection into linear regression models, using SAS PROC GLMSELECT, 
with the carotenoid concentration as the dependent variable and total energy intake forced into the 
model. Significance levels to enter and stay were 0.10 and 0.05, respectively. 
Predicted plasma carotenoid concentrations in the testing subset were calculated from the regression 
models developed in the training subset. Spearman correlations were calculated between the predicted 
and measured plasma concentrations and between the calculated dietary intakes and measured plasma 
concentrations. To determine whether the correlations with measured plasma carotenoid 
concentrations were significantly different for the predicted plasma concentrations versus calculated 
dietary intakes, Wolfe’s Test for Comparing Dependent Correlation Coefficients [18] was performed 
after taking the probit transformation of each variable’s rank divided by (n + 1) in order to convert the 
ranks to a normally-distributed scale [19]. 
Correction of the Spearman correlation coefficients for random within-person variation was 
performed by first dividing the Pearson correlation coefficients for the probit[rank/(n + 1)]-transformed 
values [19] by the square root of the product of the intraclass correlations (ICCs) for the relevant 
measures of carotenoid status (i.e., measured plasma concentration and either calculated dietary intake or 
predicted plasma concentration). The corrected Pearson correlation coefficients were then converted back 
to Spearman correlation coefficients based on the relations presented in [19]. To capture medium-term 
variation, ICCs for natural log-transformed calculated dietary intakes were determined from the  
1984 and 1986 FFQs for all NHS participants with available data. Similarly, ICCs for the natural  
log-transformed predicted plasma carotenoid concentrations were calculated among these women from 
food intakes reported on the 1984 and 1986 FFQs; outlying predicted plasma concentrations were 
removed [16]. Measured plasma carotenoid ICCs were previously reported for 40 NHS participants 
who provided two blood samples 1–2 years apart [20]. 
Interactions between selected foods and fat intake were assessed by including food-by-fat  
cross-product terms in the final selected models. Fat was quantified as grams per day, percent of 
energy per day, and salad dressing servings per day and modeled as each woman’s intake minus her 
data subset’s (i.e., training or testing) mean intake (residuals). Linear regression models including the 
relevant carotenoid’s selected foods, food-by-fat cross-products, and the main effect of fat were fit in 
the training subset. Separate models were run for each food-by-fat cross-product, and significant  
cross-products were included in the relevant model simultaneously. Final interaction models included 
only significant food-by-fat cross-products. These models were then applied to the testing subset to 
generate predicted plasma concentrations, which were compared to measured plasma concentrations 
and calculated dietary intakes as described above. 
All reported P values are 2-sided and considered statistically significant at <0.05, and all statistical 
analyses were performed using SAS version 9 [21]. 
3. Results 
Participant characteristics at blood collection are shown in Table 1. There were no appreciable 
differences between the training and testing subsets. Generally, the women were in their fifties or early 
sixties, normal-to-overweight, postmenopausal, and non-users of β-carotene supplements. 
Approximately 40% of the women used multivitamins. 
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Table 1. Participant characteristics at time of blood collection by dataset. 
Characteristic 
Training Testing 
n Mean (SD 1) or % n Mean (SD) or % 
Age (years) 2787 58.6 (6.9) 1393 58.5 (6.8) 
Body mass index (kg/m2) 2787 25.6 (4.5) 1393 25.5 (4.6) 
Multivitamin use 1116 40 578 41 
β-carotene supplement use 72 3 30 2 
Premenopausal 458 16 216 16 
Postmenopausal, no HT 1 1077 39 567 41 
Postmenopausal, HT 1013 36 500 36 
Unknown menopausal status or HT 239 9 110 8 
Daily dietary intake (μg) 2     
α-carotene 2787 776 (496) 1393 799 (509) 
β-carotene 2787 4397 (2193) 1393 4442 (2208) 
Supplemental β-carotene, 1990 2787 360 (1253) 1393 372 (1134) 
β-cryptoxanthin 2787 183 (92) 1393 184 (94) 
Lutein/zeaxanthin 2787 2955 (1635) 1393 2950 (1630) 
Lycopene 2787 6336 (3219) 1393 6321 (3200) 
Total carotenoids 2787 14,646 (5452) 1393 14,697 (5560) 
Plasma biomarker concentration 3     
α-carotene 2784 74 (50) 1387 74 (52) 
β-carotene 2706 291 (207) 1358 289 (212) 
β-cryptoxanthin 2780 84 (46) 1390 83 (43) 
Lutein/zeaxanthin 2786 187 (74) 1391 181 (68) 
Lycopene 2775 425 (176) 1384 419 (177) 
Total carotenoids 2702 1080 (403) 1356 1062 (394) 
Plasma cholesterol (mg/dL) 2494 218 (39) 1258 217 (40) 
1 Standard deviation (SD), hormone therapy (HT); 2 Energy-adjusted; 3 Plasma carotenoids (μg/L) adjusted for age,  
case-control status, body mass index, plasma cholesterol, menopausal status, and post-menopausal hormone use by the 
residual method. 
Based on the model adjusted R2, the empirical prediction models explained 5% (lycopene) to 15%  
(α-carotene and β-cryptoxanthin) of the variation in plasma carotenoid concentrations in the training 
subset. The models explained 6% (lycopene) to 16% (β-cryptoxanthin) in the testing subset (Tables 2–4). 
The individual foods explaining the largest % variation (assessed by partial R2) in each carotenoid in 
the training subset were raw carrots for α-carotene, β-carotene, and total carotenoids; orange juice for  
β-cryptoxanthin; romaine or leaf lettuce for lutein/zeaxanthin; and tomato sauce for lycopene. Most of 
these foods also explained the largest % variation in the respective carotenoid in the testing subset 
(Tables 2–4); however, orange juice explained a slightly larger percent than raw carrots for  
total carotenoids. 
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Table 2. Plasma α-carotene, β-carotene, β-cryptoxanthin multivariate linear regression models 1. 
Carotenoid Food 2 
Cohort Training (n = 2706–2784) Testing (n = 1358–1390)
% 3 β SE 4 P Partial R2 Partial R2 
α-carotene 5,6        
 Carrots, raw 29.5 0.704 0.036 <0.0001 0.121 0.107 7 
 Bananas 1.0 0.212 0.040 <0.0001 0.010 0.006 7 
 Carrots, cooked 45.9 0.418 0.087 <0.0001 0.008 0.009 7 
β-carotene 8,9        
 Carrots, raw 10.9 0.361 0.040 <0.0001 0.029 0.024 7 
 Supplemental β-carotene 6.9 0.130 0.0212 <0.0001 0.014 0.018 7 
 Broccoli 4.6 0.337 0.069 <0.0001 0.009 0.006 7 
 Lettuce, romaine or leaf 8.1 0.171 0.042 <0.0001 0.006 0.007 7 
 Cantaloupe 7.1 0.374 0.097 0.0001 0.005 0.007 7 
 Prunes 0.6 0.173 0.067 0.01 0.002 0.001 
 Pizza 0.7 −0.466 0.191 0.01 0.002 0.001 
β-cryptoxanthin 10,11        
 Juice, orange 38.3 0.267 0.019 <0.0001 0.066 0.080 7 
 Oranges 16.0 0.435 0.039 <0.0001 0.043 0.048 7 
 Peaches, apricots, or plums 6.3 0.233 0.048 <0.0001 0.008 0.012 7 
 Carrots, raw 3.4 0.136 0.031 <0.0001 0.007 0.001 
 Apples or pears, fresh 2.4 0.124 0.029 <0.0001 0.007 0.007 7 
 Corn 6.6 −0.298 0.083 0.0003 0.005 0.000 
 Prunes 3.1 0.130 0.053 0.01 0.002 0.003 7 
 Cucumbers 2.3 −0.064 0.028 0.02 0.002 0.001 
1 Plasma concentrations were natural log transformed and adjusted for age, case-control status, body mass index, plasma cholesterol, menopausal status, and hormone therapy use by the 
residual method; 2 Foods (servings/day; milligrams/day for supplemental β-carotene) selected among the training subset by stepwise selection from all foods contributing ≥0.5% to specific 
carotenoid intake in the full cohort with 0.10 significance level to enter and 0.05 significance level to stay; 3 1986–1990 average percent contribution to total intake in the full cohort; 
supplemental β-carotene intake is 1990 only; 4 Standard error (SE); 5 Intercept = 3.98, β (SE) for total energy intake = −0.0000798 (0.0000249); 6 Model adjusted R2 = 0.15 in training and 
0.12 in testing; 7 P < 0.05; 8 Intercept = 5.36, β (SE) for total energy intake = −0.0000758 (0.0000274); 9 Model adjusted R2 = 0.09 in training and 0.08 in testing; 10 Intercept = 4.12, β (SE) 
for total energy intake = −0.0000602 (0.0000223); 11 Model adjusted R2 = 0.15 in training and 0.16 in testing. 
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Table 3. Plasma lutein/zeaxanthin, lycopene multivariate linear regression models 1. 
Carotenoid Food 2 
Cohort Training (n = 2775–2786) Testing (n = 1384–1391) 
% 3 β SE 4 P Partial R2 Partial R2 
lutein/zeaxanthin 5,6 Lettuce, romaine or leaf 7.8 0.164 0.026 <0.0001 0.014 0.025 7 
 Juice, orange 3.1 0.085 0.015 <0.0001 0.011 0.020 7 
 Broccoli 8.6 0.185 0.045 <0.0001 0.006 0.009 7 
 Spinach, cooked 21.7 0.334 0.105 0.002 0.004 0.001 
 Carrots, raw 0.6 0.082 0.025 0.001 0.004 0.001 
 Eggs 1.3 0.105 0.036 0.003 0.003 0.006 7 
 Spinach, raw 11.7 0.224 0.093 0.02 0.002 0.002 
 Eggplant/zucchini/other summer squash 3.1 0.165 0.072 0.02 0.002 0.002 
 Tomatoes 1.8 0.059 0.026 0.03 0.002 0.000 
 Corn 2.5 −0.146 0.066 0.03 0.002 0.000 
 Oranges 1.1 0.063 0.030 0.03 0.002 0.001 
 Popcorn 0.6 0.045 0.022 0.04 0.002 0.007 7 
Lycopene 8,9        
 Tomato sauce 42.4 0.553 0.073 <0.0001 0.020 0.031 7 
 Pizza 15.2 0.648 0.137 <0.0001 0.008 0.007 7 
 Tomatoes 16.7 0.131 0.029 <0.0001 0.007 0.004 7 
 Juice, tomatoes 11.9 0.213 0.072 0.003 0.003 0.08 7 
1 Plasma concentrations were natural log transformed and adjusted for age, case-control status, body mass index, plasma cholesterol, menopausal status, and hormone therapy use by the 
residual method; 2 Foods (servings/day; milligrams/day for supplemental β-carotene) selected among the training subset by stepwise selection from all foods contributing ≥0.5% to specific 
carotenoid intake in the full cohort with 0.10 significance level to enter and 0.05 significance level to stay; 3 1986–1990 average percent contribution to total intake in the full cohort; 
supplemental β-carotene intake is 1990 only; 4 Standard error (SE); 5 Intercept = 5.03, β (SE) for total energy intake = −0.0000612 (0.0000182); 6 Model adjusted R2 = 0.08 in training and 
0.09 in testing; 7 P < 0.05; 8 Intercept = 5.91, β (SE) for total energy intake = −0.0000705 (0.0000198); 9 Model adjusted R2 = 0.05 in training and 0.06 in testing. 
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Table 4. Plasma total carotenoids multivariate linear regression model 1,2,3. 
Food 4 
Cohort Training (n = 2702) Testing (n = 1356) 
% 5 β SE 6 P Partial R2 Partial R2 
Carrots, raw 4.9 0.176 0.024 <0.0001 0.019 0.017 7 
Lettuce, romaine or leaf 3.9 0.111 0.025 <0.0001 0.007 0.006 7 
Oranges 0.6 0.119 0.029 <0.0001 0.006 0.005 7 
Juice, orange 1.3 0.058 0.014 <0.0001 0.006 0.020 7 
Tomato sauce 19.4 0.242 0.061 <0.0001 0.006 0.012 7 
Broccoli 3.1 0.131 0.041 0.002 0.004 0.003 
Corn 0.6 −0.188 0.063 0.003 0.003 0.000 
Cantaloupe 2.1 0.126 0.059 0.03 0.002 0.003 7 
Tomatoes 9.4 0.054 0.025 0.03 0.002 0.000 
1 Plasma total carotenoid concentrations were natural log transformed and adjusted for age, case-control status, body mass 
index, plasma cholesterol, menopausal status, and hormone therapy use by the residual method; 2 Intercept = 6.84, β (SE) 
for total energy intake = −0.0000649 (0.0000174); 3 Model adjusted R2 = 0.07 in training and 0.08 in testing;  
4 Foods (servings/day) selected among the training subset by stepwise selection from all foods contributing ≥0.5% to total 
carotenoids intake in the full cohort with 0.10 significance level to enter and 0.05 significance level to stay; 5 1986–1990 
average percent contribution to total intake in the full cohort; supplemental β-carotene is 1990 only; 6 Standard error (SE); 
7 P < 0.05. 
The Spearman correlations with measured plasma concentrations were higher for predicted than 
calculated dietary intake for all carotenoids in both subsets, excluding lycopene in the training subset 
(Table 5). In the training subset, the correlations with measured plasma concentration were 
significantly different between calculated diet and predicted for all carotenoids except lycopene. In the 
testing subset, the correlations were significantly different from one another for α-carotene and  
β-cryptoxanthin and borderline-significantly different from one another for lutein/zeaxanthin and  
total carotenoids. 
Table 5. Spearman correlation coefficients for calculated dietary carotenoid intake 1 (r1) or 
predicted plasma carotenoid concentration (r2) with measured plasma carotenoid 
concentration 2 in the training (n = 2702–2786) and testing subsets (n = 1356–1391). 
 Training Testing 
Carotenoid r1 r2 r1  r2 P 3 
α-carotene 0.34 0.41 0.31 0.37 0.0001 
β-carotene 0.26 0.30 0.29 0.31 0.35 
β-cryptoxanthin 0.34 0.42 0.36 0.41 0.02 
Lutein/zeaxanthin 0.26 0.30 0.28 0.31 0.05 
Lycopene 0.22 0.21 0.22 0.23 0.81 
Total carotenoids 0.20 0.27 0.22 0.27 0.07 
1 Energy-adjusted, natural log-transformed; 2 Natural log-transformed and adjusted for age, case-control status, body 
mass index, plasma cholesterol, menopausal status, and post-menopausal hormone use by the residual method; 3 P-value 
from Wolfe’s test for comparing dependent correlations (r1 and r2) calculated from probit[rank/(n + 1)]-transformed 
carotenoid measures; P-values in training subset ≤0.005 for all carotenoids other than lycopene (P = 0.34). 
Nutrients 2013, 5 4060 
 
ICCs (95% confidence interval) for calculated dietary carotenoid intake over 2 years in  
47,233–48,076 NHS participants were 0.51 (0.50–0.51) for α-carotene, 0.62 (0.61–0.62) for  
β-carotene, 0.58 (0.57–0.58) for β-cryptoxanthin, 0.64 (0.63–0.64) for lutein/zeaxanthin,  
0.43 (0.42–0.44) for lycopene, and 0.55 (0.54–0.55) for total carotenoids. ICCs (95% CI) for the 
predicted plasma carotenoid concentrations over 2 years in 46,829–47,850 NHS participants were  
0.54 (0.53–0.54) for α-carotene, 0.60 (0.59–0.60) for β-carotene, 0.56 (0.55–0.57) for β-cryptoxanthin, 
0.62 (0.61–0.62) for lutein/zeaxanthin, 0.43 (0.42–0.44) for lycopene, and 0.59 (0.58–0.59) for total 
carotenoids. As reported previously, the ICCs for two measured plasma carotenoid concentrations over 
1–2 years in 40 NHS participants ranged from 0.73 (α- and β-carotene) to 0.88 (β-cryptoxanthin) [20]. 
Using these ICCs to correct for medium-term random variation, Spearman correlations for calculated 
dietary intake and measured plasma concentrations corrected for random within-person variation in the 
training and testing subsets, respectively, were 0.55 and 0.51 for α-carotene, 0.38 and 0.42 for  
β-carotene, 0.47 and 0.50 for β-cryptoxanthin, 0.36 and 0.37 for lutein/zeaxanthin, 0.41 and 0.44 for 
lycopene, and 0.31 and 0.34 for total carotenoids. The Spearman correlations for predicted and 
measured plasma concentrations corrected for random within-person variation in the training and 
testing subsets, respectively, were 0.66 and 0.61 for α-carotene, 0.44 and 0.45 for β-carotene, 0.58 and 
0.56 for β-cryptoxanthin, 0.42 and 0.43 for lutein/zeaxanthin, 0.40 and 0.44 for lycopene, and 0.39 and 
0.39 for total carotenoids. 
While some significant interactions with fat intake were observed, prediction was only improved 
for lutein/zeaxanthin (data not shown). Salad dressing significantly modified the relation between both 
broccoli and raw carrots and plasma lutein/zeaxanthin in the training subset (P = 0.02, 0.01, 
respectively) where the associations decreased with higher salad dressing intake. The testing subset 
lutein/zeaxanthin predicted-measured plasma concentration Spearman correlation increased 
significantly (P = 0.03) to 0.32 with the inclusion of the interaction term. To obtain the most precise 
regression coefficients possible for the empirical prediction models, we ran stepwise selection for each 
carotenoid among all participants (Table S2). Tomatoes were selected for α-carotene in all women, but 
they were not selected in the training subset. Peas or lima beans; yams or sweet potatoes; and kale, 
mustard, or chard greens were selected for β-carotene in all women but not in the training subset. For 
lutein/zeaxanthin, kale, mustard, or chard greens were selected in all women but not in the training 
subset, and corn and tomatoes were selected in the training subset but not in all women. Tomato juice, 
peas or lima beans, and yams or sweet potatoes were selected for total carotenoids in all women but 
not in the training subset, and corn and tomatoes were selected in the training subset but not in all 
women. Most regression coefficients for foods selected in both datasets were similar. Spearman 
correlations with measured plasma concentrations for the calculated dietary intakes and predicted 
plasma concentrations, respectively, were 0.33 and 0.40 for α-carotene, 0.27 and 0.31 for  
β-carotene, 0.35 and 0.42 for β-cryptoxanthin, 0.26 and 0.31 for lutein/zeaxanthin, 0.22 and 0.22 for 
lycopene, and 0.20 and 0.27 for total carotenoids. 
To make the linear regression β-coefficients comparable across foods, 1986 and 1990 average food 
intakes were converted from servings/day to μg/day of each carotenoid from each food. After this 
conversion, all foods contributing ≥0.5% to the full cohort’s intake of the carotenoid of interest, 
excluding margarine for β-carotene and cold breakfast cereal for lutein/zeaxanthin, were included in 
linear regression models (Table S3). In general, β-coefficients varied widely across foods, and intake 
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of some carotenoids from specific foods, such as α-carotene from bananas and β-cryptoxanthin from 
apples or pears, were strongly related to plasma concentrations of those carotenoids. Additionally,  
β-coefficients tended to be larger for β-cryptoxanthin than for the other carotenoids. 
4. Discussion 
The empirical prediction models for plasma carotenoids we developed with FFQ food items 
included foods expected to be major predictors of the individual carotenoids and some foods likely 
selected by chance or dietary patterns. The Spearman correlations with measured plasma concentration 
were modestly yet significantly or borderline-significantly different between calculated diet and 
predicted levels for all carotenoids except β-carotene and lycopene. Our results suggest calculated 
intake from published nutrient contents adequately represents bioavailable intake of most carotenoids, 
but α-carotene, β-cryptoxanthin, and, if taking salad dressing intake into account, lutein/zeaxanthin, 
may benefit slightly from empirical prediction models. 
Major food predictors of each plasma carotenoid were expected. Based on percent of variation in 
plasma concentrations explained in the training subset, raw carrots were most predictive of plasma  
α- and β-carotene and total carotenoids. Raw and/or cooked carrots have been identified as α- and  
β-carotene predictors [10,22] and were top contributors to intake of both carotenoids. Raw carrots may 
have been more informative than cooked because they were consumed more frequently with greater 
variation in the training subset (data not shown). Orange juice and oranges were most predictive of 
plasma β-cryptoxanthin, a logical association given previous selection of orange juice as a  
β-cryptoxanthin predictor in the NHS [22] and the fact that juice and oranges are assessed well by FFQ 
(FFQ-diet records r = 0.84 for orange/grapefruit juice, 0.74 for oranges) [7]. While not the top 
contributor to intake, romaine or leaf lettuce may have been most predictive of plasma 
lutein/zeaxanthin because the frequency of and variation in consumption was generally larger than that 
of the top contributors (data not shown). Tomato sauce’s predictiveness of plasma lycopene follows 
lycopene’s enhanced bioavailability in processed versus raw tomatoes [23], the large contribution of 
tomato sauce to the cohort’s lycopene intake, and studies with similar FFQs [22,24]. 
Some foods with negligible contributions to carotenoid intake and/or inverse regression coefficients 
also were selected. Chance may be, in part, responsible given that we tested many foods at a P < 0.05 
model staying criterion. Cucumbers and/or corn had inverse regression coefficients in the  
β-cryptoxanthin, lutein/zeaxanthin, and total carotenoids models, though they were not significant in 
the testing subset. Although they contributed ≤1% to intake, bananas, prunes, raw carrots, and oranges 
may have been selected for some carotenoids due to correlations among foods. Fruits and vegetables 
are positively associated with the prudent dietary pattern [25], and in men utilizing a similar FFQ, the 
prudent dietary pattern was positively correlated with plasma carotenoid concentrations while the 
Western dietary pattern was inversely correlated [26]. Pizza, which contributed ≤1% to β-carotene 
intake and had an inverse regression coefficient, is associated with a Western dietary pattern [25] 
Popcorn contributed <1% to lutein/zeaxanthin intake and is in a food group (snacks) associated with a 
Western dietary pattern [25] but was significantly positively associated with plasma lutein/zeaxanthin. 
Popping and likely co-consumption of butter/oil may enhance popcorn’s lutein/zeaxanthin 
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bioavailability, but these hypotheses require further investigation, especially given no observed 
interaction between fat and popcorn in relation to plasma lutein/zeaxanthin. 
The correlations with measured plasma concentrations were only modestly different between 
predicted plasma carotenoid concentrations and calculated dietary intakes. Relative errors in the 
empirical weights and nutrient database likely varied across foods and carotenoids and may have 
contributed to the equivalency in methods. The adequacy of calculated dietary β-carotene intake in 
representing plasma concentrations confirms a previous analysis [10]. Here, the most significant 
improvements were observed for α-carotene and β-cryptoxanthin. The α-carotene prediction model 
may have performed well because one food (carrots) was the main contributor to intake and main 
predictor of plasma concentrations. The empirical weights may have less error than α-carotene 
contents assigned to carrots by accounting for bioavailability and assessment validity and by 
eliminating the nutrient database. Factors such as storage and cultivar can influence carotenoid content 
of foods [27], and the sample of carrots used to determine the nutrient database α-carotene content may 
not represent the mix of carrots our participants consumed. Further, the only other food selected for  
α-carotene was bananas. Compared to carrots, each μg/day increase in banana α-carotene intake was 
more strongly associated with increased plasma α-carotene concentrations, possibly due to 
bioavailability. Accounting for bioavailability may explain the better performance of the α-carotene 
prediction model over calculated dietary intakes. The β-cryptoxanthin prediction model may have 
benefitted similarly. Oranges and orange juice were the major contributors to intake and strongest 
predictors of plasma concentrations. Each μg/day increase in β-cryptoxanthin from several foods was 
associated with a greater increase in plasma β-cryptoxanthin than was a μg/day increase in the other 
carotenoids from specific foods in relation to plasma concentrations of those carotenoids. An enhanced 
apparent bioavailability (e.g., greater increases in plasma levels from the same amount of intake) of  
β-cryptoxanthin and, to a smaller extent, α-carotene versus β-carotene, has been reported previously [28], 
further supporting a possible benefit of considering bioavailability when assessing exposure for  
those carotenoids. 
Strengths of this analysis include the large sample size, testing the prediction models in a separate 
group of participants, and use of repeated, extensive FFQs. There are also limitations to this analysis 
and thus the empirical prediction models. A large proportion of variation in plasma carotenoid 
concentrations was unexplained, possibly due in part to using a single plasma measurement per 
woman. However, fairly high ICCs for the plasma carotenoids over a 1–2 year period (0.73–0.88) 
suggest a single measurement adequately represents longer-term exposure [20]. While we did not 
account for all factors known to influence plasma carotenoid concentrations, such as genetic  
variation [29–31], this is expected to reduce precision and not introduce bias because the sources of 
unexplained variation are not likely related to food consumption frequency. In addition, these models 
were restricted to non-smokers, and as such, may not apply to populations with a large number of 
smokers. The empirical prediction models also only apply to this cohort because they are mixtures of 
biological and behavioral associations. To the extent associations differ in other populations, error will 
occur. If dietary patterns in another population differ, for instance carotenoid-containing foods are 
more frequently consumed with fats, different conclusions regarding the correlations between 
biomarkers and predicted vs. calculated carotenoid intake may be reached. Although our testing subset 
was restricted to the NHS blood subcohort, it is likely the models apply to the full cohort and/or FFQs 
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administered at different times. Our ability to use the empirical prediction models on all FFQs 
administered to the full cohort may offset the reduced precision from unexplained variation in plasma 
carotenoid concentrations, but accommodating changes in food items on the FFQ over time may 
introduce additional error. In addition, this approach does not address any inherent measurement error 
in the FFQ. Finally, these analyses require both measured biomarkers as well as calculated intake of 
carotenoids, as such, this complex approach may not be easily applied in other settings. 
5. Conclusions 
In summary, we confirmed the utility of determining carotenoid intake from published nutrient 
contents and further validated the NHS FFQ for carotenoid assessment. This validation of FFQs is 
beneficial, not only because FFQs are easily measured in large populations but also because translating 
findings from intakes is more feasible than from plasma levels in terms of generating public health 
messages. Empirical prediction models may modestly improve bioavailable α-carotene,  
β-cryptoxanthin, and possibly lutein/zeaxanthin assessment. As the prediction models presented here 
are specific to the NHS, this approach is worth considering in other cohorts where larger 
improvements may be observed. Finally, although the improvements using empirical prediction 
models were modest, it would be of interest to assess if these improvements result in any change in 
association between intake of carotenoids and chronic disease risk. 
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